Vivian Abascal is a Cardiology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 37 publications with 5,012 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
117-10 Hillside Avenue
Richmond Hill, NY 11419
Telephone
718-297-0440Registry record last updated 3 Nov 2014.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Shockwave Medical, IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.9%Statin18.9%Atorvastatin Calcium61%Rosuvastatin Calcium25%Simvastatin8%Pravastatin Sodium6%Part D<11 patientsCalcium channel blocker14.9%Amlodipine Besylate95%Amlodipine Besylate-Benazepril5%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
7.2%SGLT2 inhibitor5.5%Jardiance81%Farxiga20%Part D<11 patientsProton pump inhibitor1.8%Omeprazole65%Pantoprazole Sodium35%Part D<11 patientsBlood & clotting
5.4%Factor Xa inhibitor4.7%Eliquis90%Xarelto11%Part D<11 patientsP2Y12 inhibitor0.8%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiac tumors: Updated classifications and main clinico-pathologic findings
Trends in Cardiovascular Medicine
2025 - Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Cardiovascular Drugs and Therapy
2023 - Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
Journal of the American College of Cardiology
2020 - PRETREATMENT WITH SGLT2 INHIBITORS AMELIORATES CONTRAST-INDUCED NEPHROPATHY
Journal of the American College of Cardiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”